MedPath

TheraVitae Ltd.

🇮🇱Israel
Ownership
Private
Employees
-
Market Cap
-
Website

ACPs in Severe PAD/CLI by Direct Intramuscular Injection

Phase 1
Completed
Conditions
Peripheral Arterial Disease
Critical Limb Ischemia
First Posted Date
2007-08-31
Last Posted Date
2007-08-31
Lead Sponsor
TheraVitae Ltd.
Target Recruit Count
6
Registration Number
NCT00523731
Locations
🇮🇱

Dr. Valentin Fulga, Tel viv, P.O.B.4049,Ness Ziona, Israel

ACPs Combined With CABG in Patients With CHF

Phase 1
Conditions
Congestive Heart Failure
Interventions
Procedure: Angiogenic Cell Precursors(ACPs) or Vescell TM
Biological: Angiogenic Cell Precusors
First Posted Date
2007-08-31
Last Posted Date
2007-08-31
Lead Sponsor
TheraVitae Ltd.
Target Recruit Count
5
Registration Number
NCT00523224
Locations
🇮🇱

Theravitae Co., Tel viv, P.O. B 4049,Ness Ziona, Israel

Vescell(TM) for the Treatment of Patients With Severe Anginal Syndrome With or Without Heart Failure

Phase 1
Conditions
Angina Pectoris
Interventions
Procedure: Intracoronary administration of autologous ACPs
First Posted Date
2006-12-28
Last Posted Date
2007-09-03
Lead Sponsor
TheraVitae Ltd.
Target Recruit Count
10
Registration Number
NCT00416663
Locations
🇮🇱

Shaare Zedek Medical Center, Jerusalem, Israel

EPC by Intracoronary Injection in Patients With Chronic Stable Angina

Phase 2
Conditions
Coronary Artery Disease
First Posted Date
2006-10-06
Last Posted Date
2006-10-20
Lead Sponsor
TheraVitae Ltd.
Target Recruit Count
24
Registration Number
NCT00384514
Locations
🇮🇱

Dr. Valentin Fulga, Kiryat Weizmann Science Park, Nes Zionna, Israel

© Copyright 2025. All Rights Reserved by MedPath